Phase II Evaluation of Exhaled Nitric Oxide (NO)
Completed
Conditions studied: Lung Cancer
In brief
The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.
Key facts
- Study ID
- NCT01392144
- Run by
- M.D. Anderson Cancer Center
- People needed
- 36
- Starts
- 2011-08-01
- Expected to finish
- 2013-02-01
- Last updated by the study team
- 2013-04-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients will sign consent for the study.
- Patients with pathologic diagnosis of esophagus or lung cancer.
- Patient plans to receive radiation treatment at MD Anderson.
- Patient will receive >/= 5 weeks of thoracic radiotherapy.
- Patients >/= 18 years of age.
You may not qualify if…
- Patients who have asthma.
- Women of childbearing potential (A woman of child-bearing potential is a sexually mature woman who has not undergone a hysterectomy or who has not been naturally postmenopausal for at least 24 consecutive months [i.e., who has had menses at any time in the preceding 24 consecutive months]) must practice effective contraception (oral, injectable, or implantable hormonal contraceptive; tubal ligation; intra-uterine device; barrier contraceptive with spermicide) throughout the study.
Where it is running
- UT MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.